Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 14 November 2003:
Vol. 302. no. 5648, pp. 1223 - 1227
DOI: 10.1126/science.1088949
Prev | Table of Contents | Next

Reports

Islet Regeneration During the Reversal of Autoimmune Diabetes in NOD Mice

Shohta Kodama, Willem Kühtreiber, Satoshi Fujimura, Elizabeth A. Dale, Denise L. Faustman*

Nonobese diabetic (NOD) mice are a model for type 1 diabetes in humans. Treatment of NOD mice with end-stage disease by injection of donor splenocytes and complete Freund's adjuvant eliminates autoimmunity and permanently restores normoglycemia. The return of endogenous insulin secretion is accompanied by the reappearance of pancreatic ß cells. We now show that live donor male or labeled splenocytes administered to diabetic NOD females contain cells that rapidly differentiate into islet and ductal epithelial cells within the pancreas. Treatment with irradiated splenocytes is also followed by islet regeneration, but at a slower rate. The islets generated in both instances are persistent, functional, and apparent in all NOD hosts with permanent disease reversal.

Immunobiology Laboratory, Massachusetts General Hospital and Harvard Medical School, Building 149, 13th Street, Room 3602, Charlestown, MA 02129, USA.

* To whom correspondence should be addressed. E-mail: faustman{at}helix.mgh.harvard.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Age-Dependent Decline in {beta}-Cell Proliferation Restricts the Capacity of {beta}-Cell Regeneration in Mice.
S.-I. Tschen, S. Dhawan, T. Gurlo, and A. Bhushan (2009)
Diabetes 58, 1312-1320
   Abstract »    Full Text »    PDF »
Combination Therapy With Glucagon-Like Peptide-1 and Gastrin Restores Normoglycemia in Diabetic NOD Mice.
W. L. Suarez-Pinzon, R. F. Power, Y. Yan, C. Wasserfall, M. Atkinson, and A. Rabinovitch (2008)
Diabetes 57, 3281-3288
   Abstract »    Full Text »    PDF »
Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes.
P. Fiorina, A. Vergani, S. Dada, M. Jurewicz, M. Wong, K. Law, E. Wu, Z. Tian, R. Abdi, I. Guleria, et al. (2008)
Diabetes 57, 3013-3024
   Abstract »    Full Text »    PDF »
Hematopoietic Mixed Chimerism Derived from Allogeneic Embryonic Stem Cells Prevents Autoimmune Diabetes Mellitus in NOD Mice.
L. Verda, D. A. Kim, S. Ikehara, L. Statkute, D. Bronesky, Y. Petrenko, Y. Oyama, X. He, C. Link, N. N. Vahanian, et al. (2008)
Stem Cells 26, 381-386
   Abstract »    Full Text »    PDF »
Innocuous IFN{gamma} induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production.
R. Jain, D. M. Tartar, R. K. Gregg, R. D. Divekar, J. J. Bell, H.-H. Lee, P. Yu, J. S. Ellis, C. M. Hoeman, C. L. Franklin, et al. (2008)
J. Exp. Med. 205, 207-218
   Abstract »    Full Text »    PDF »
Inability to process and store proinsulin in transdifferentiated pancreatic acinar cells lacking the regulated secretory pathway.
A Alidibbiat, C E Marriott, K T Scougall, S C Campbell, G C Huang, W M Macfarlane, and J A M Shaw (2008)
J. Endocrinol. 196, 33-43
   Abstract »    Full Text »    PDF »
Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of Diabetes.
V. S. Urban, J. Kiss, J. Kovacs, E. Gocza, V. Vas, E. Monostori, and F. Uher (2008)
Stem Cells 26, 244-253
   Abstract »    Full Text »    PDF »
Hematopoietic Stem Cells Derived From Adult Donors Are Not a Source of Pancreatic {beta}-Cells in Adult Nondiabetic Humans.
A. E. Butler, A. Huang, P. N. Rao, A. Bhushan, W. J. Hogan, R. A. Rizza, and P. C. Butler (2007)
Diabetes 56, 1810-1816
   Abstract »    Full Text »    PDF »
Reversal of Sjogren's-like syndrome in non-obese diabetic mice.
S. D Tran, S. Kodama, B. M Lodde, I. Szalayova, S. Key, S. Khalili, D. L Faustman, and E. Mezey (2007)
Ann Rheum Dis 66, 812-814
   Abstract »    Full Text »    PDF »
Elimination of insulitis and augmentation of islet beta cell regeneration via induction of chimerism in overtly diabetic NOD mice.
C. Zhang, I. Todorov, C.-L. Lin, M. Atkinson, F. Kandeel, S. Forman, and D. Zeng (2007)
PNAS 104, 2337-2342
   Abstract »    Full Text »    PDF »
VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites.
S. Hirakawa, L. F. Brown, S. Kodama, K. Paavonen, K. Alitalo, and M. Detmar (2007)
Blood 109, 1010-1017
   Abstract »    Full Text »    PDF »
Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism.
J. L. Nelson, K. M. Gillespie, N. C. Lambert, A. M. Stevens, L. S. Loubiere, J. C. Rutledge, W. M. Leisenring, T. D. Erickson, Z. Yan, M. E. Mullarkey, et al. (2007)
PNAS 104, 1637-1642
   Abstract »    Full Text »    PDF »
Reversal of Type 1 Diabetes in Mice.
D. L. Faustman (2007)
N. Engl. J. Med. 356, 311-312
   Full Text »    PDF »
Recovery of Islet {beta}-Cell Function in Streptozotocin- Induced Diabetic Mice: An Indirect Role for the Spleen.
D. Yin, J. Tao, D. D. Lee, J. Shen, M. Hara, J. Lopez, A. Kuznetsov, L. H. Philipson, and A. S. Chong (2006)
Diabetes 55, 3256-3263
   Abstract »    Full Text »    PDF »
Chromatin-Remodeling Factors Allow Differentiation of Bone Marrow Cells into Insulin-Producing Cells.
T. Tayaramma, B. Ma, M. Rohde, and H. Mayer (2006)
Stem Cells 24, 2858-2867
   Abstract »    Full Text »    PDF »
Comment on Papers by Chong et al., Nishio et al., and Suri et al. on Diabetes Reversal in NOD Mice.
D. L. Faustman, S. D. Tran, S. Kodama, B. M. Lodde, I. Szalayova, S. Key, Z. E. Toth, and E. Mezey (2006)
Science 314, 1243a
   Abstract »    Full Text »    PDF »
Response to Comment on Chong et al. on Diabetes Reversal in NOD Mice.
A. S. Chong, J. Shen, J. Tao, D. Yin, A. Kuznetsov, M. Hara, and L. H. Philipson (2006)
Science 314, 1243b
   Abstract »    Full Text »    PDF »
Response to Comment on Nishio et al. on Diabetes Reversal in NOD Mice.
J. Nishio, J. L. Gaglia, S. E. Turvey, C. Campbell, C. Benoist, and D. Mathis (2006)
Science 314, 1243c
   Abstract »    Full Text »    PDF »
Response to Comment on Suri et al. on Diabetes Reversal in NOD Mice.
A. Suri and E. R Unanue (2006)
Science 314, 1243d
   Abstract »    Full Text »    PDF »
Reversal of type 1 diabetes in mice..
D. A. Melton (2006)
N. Engl. J. Med. 355, 89-90
   Full Text »    PDF »
Fluorescent Immunohistochemistry and In Situ Hybridization Analysis of Mouse Pancreas Using Low-power Antigen-retrieval Technique.
S. Ge, G. M. Crooks, G. McNamara, and X. Wang (2006)
J. Histochem. Cytochem. 54, 843-847
   Abstract »    Full Text »    PDF »
Ontogeny of Regeneration of {beta}-Cells in the Neonatal Rat after Treatment with Streptozotocin.
S. Thyssen, E. Arany, and D. J. Hill (2006)
Endocrinology 147, 2346-2356
   Abstract »    Full Text »    PDF »
Selective Deletion of Pten in Pancreatic {beta} Cells Leads to Increased Islet Mass and Resistance to STZ-Induced Diabetes..
B. L. Stiles, C. Kuralwalla-Martinez, W. Guo, C. Gregorian, Y. Wang, J. Tian, M. A. Magnuson, and H. Wu (2006)
Mol. Cell. Biol. 26, 2772-2781
   Abstract »    Full Text »    PDF »
Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration..
A. S. Chong, J. Shen, J. Tao, D. Yin, A. Kuznetsov, M. Hara, and L. H. Philipson (2006)
Science 311, 1774-1775
   Abstract »    Full Text »    PDF »
Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution..
J. Nishio, J. L. Gaglia, S. E. Turvey, C. Campbell, C. Benoist, and D. Mathis (2006)
Science 311, 1775-1778
   Abstract »    Full Text »    PDF »
Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells..
A. Suri, B. Calderon, T. J. Esparza, K. Frederick, P. Bittner, and E. R. Unanue (2006)
Science 311, 1778-1780
   Abstract »    Full Text »    PDF »
Formation of Pancreatic Duct Epithelium from Bone Marrow During Neonatal Development.
X. Wang, S. Ge, I. Gonzalez, G. McNamara, C. B. Rountree, K. K. Xi, G. Huang, A. Bhushan, and G. M. Crooks (2006)
Stem Cells 24, 307-314
   Abstract »    Full Text »    PDF »
Characterization of Mouse Spleen Cells by Subtractive Proteomics.
F. J. Dieguez-Acuna, S. A. Gerber, S. Kodama, J. E. Elias, S. A. Beausoleil, D. Faustman, and S. P. Gygi (2005)
Mol. Cell. Proteomics 4, 1459-1470
   Abstract »    Full Text »    PDF »
Combination Therapy With Epidermal Growth Factor and Gastrin Increases {beta}-Cell Mass and Reverses Hyperglycemia in Diabetic NOD Mice.
W. L. Suarez-Pinzon, Y. Yan, R. Power, S. J. Brand, and A. Rabinovitch (2005)
Diabetes 54, 2596-2601
   Abstract »    Full Text »    PDF »
Human Cord Blood-Derived Cells Generate Insulin-Producing Cells In Vivo.
S. Yoshida, F. Ishikawa, N. Kawano, K. Shimoda, S. Nagafuchi, S. Shimoda, M. Yasukawa, T. Kanemaru, H. Ishibashi, L. D. Shultz, et al. (2005)
Stem Cells 23, 1409-1416
   Abstract »    Full Text »    PDF »
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets.
V. Sordi, M. L. Malosio, F. Marchesi, A. Mercalli, R. Melzi, T. Giordano, N. Belmonte, G. Ferrari, B. E. Leone, F. Bertuzzi, et al. (2005)
Blood 106, 419-427
   Abstract »    Full Text »    PDF »
VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis.
S. Hirakawa, S. Kodama, R. Kunstfeld, K. Kajiya, L. F. Brown, and M. Detmar (2005)
J. Exp. Med. 201, 1089-1099
   Abstract »    Full Text »    PDF »
Donor CD8+ T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb.
Y. Liang, T. Huang, C. Zhang, I. Todorov, M. Atkinson, F. Kandeel, S. Forman, and D. Zeng (2005)
Blood 105, 2180-2188
   Abstract »    Full Text »    PDF »
Diabetes and Stem Cell Researchers Turn to the Lowly Spleen.
S. Kodama, M. Davis, and D. L. Faustman (2005)
Sci. Aging Knowl. Environ. 2005, pe2
   Abstract »    Full Text »
Cure of Overt Diabetes in NOD Mice by Transient Treatment With Anti-Lymphocyte Serum and Exendin-4.
N. Ogawa, J. F. List, J. F. Habener, and T. Maki (2004)
Diabetes 53, 1700-1705
   Abstract »    Full Text »    PDF »
In Vivo and In Vitro Characterization of Insulin-Producing Cells Obtained From Murine Bone Marrow.
D.-Q. Tang, L.-Z. Cao, B. R. Burkhardt, C.-Q. Xia, S. A. Litherland, M. A. Atkinson, and L.-J. Yang (2004)
Diabetes 53, 1721-1732
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)